Director Erin M. Stone filed a Form 4 with the SEC on November 9, 2026, disclosing a purchase of 500 shares of Security Midwest Bancorp, Inc. common stock on November 6, 2026.
Director David Sidransky filed a Form 4 with the SEC on November 9, 2026, disclosing the acquisition of options to purchase 31,216 shares of Champions Oncology, Inc. common stock at an exercise price of $4.76 per share, with a transaction date of November 5, …
Jose Mendez-Andino, EVP and Chief Innovation Officer at Owens Corning, filed a Form 4 on November 9, 2026, reporting the acquisition of 94.109 shares of common stock on November 5, 2026, through the accrual of dividend equivalents on deferred shares.
Director Adrienne Elsner filed a Form 4 with the SEC on November 9, 2026, disclosing two acquisitions of Owens Corning common stock on November 5 and November 6, 2026.
Director Suzanne P. Nimocks filed a Form 4 with the SEC on November 9, 2026, disclosing two acquisitions of Owens Corning common stock on November 5 and November 6, 2026.
Director Alfred E. Festa filed a Form 4 with the SEC on November 9, 2026, disclosing two acquisitions of Owens Corning common stock on November 5 and November 6, 2026.
Director Michael J. DeVito filed a statement of changes in beneficial ownership with the SEC on November 9, 2026, disclosing a transaction in Owens Corning common stock dated November 6, 2026.
Director Eduardo E. Cordeiro filed a Form 4 with the SEC on November 9, 2026, disclosing two acquisitions of Owens Corning common stock on November 5 and November 6, 2026.
Director John David Williams filed a Form 4 with the SEC on November 9, 2026, reporting two acquisitions of Owens Corning common stock on November 5 and November 6, 2026.
Director Paul Edward Martin filed a Form 4 with the SEC on November 9, 2026, disclosing two acquisitions of Owens Corning common stock on November 5 and November 6, 2026.